{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-028348","form_type":"8-K","ticker":"EVFM","cik":"0001618835","company_name":"Evofem Biosciences, Inc.","filed_at":"2024-07-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.819921+00:00","generated_at":"2026-05-31T19:41:49.101852+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Evofem, Aditxt sign amended merger with $1.8M cash and preferred stock","bullets":["Aditxt to pay up to $1.8M cash for Evofem common stock, less dissenting shares; preferred stock exchange also specified.","Aditxt commits to purchase $4M of Evofem Series F-1 Preferred Stock in staged tranches by Sept 30, 2024.","Merger conditions include shareholder approvals, warrant exchanges, and $150K cap on warrant cash-outs.","Evofem board unanimously recommends merger; proxy statement to be filed with SEC."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-028348","json":"https://secwatch.observer/filing/0001493152-24-028348.json","markdown":"https://secwatch.observer/filing/0001493152-24-028348.md","text":"https://secwatch.observer/filing/0001493152-24-028348.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224028348/0001493152-24-028348-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1618835/000149315224028348/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T19:41:49.101852+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}